Glycopyrrolate
- Product NDC
- 70518-3031
- Requested package NDC
- 70518-3031-0
- 11-digit product format
- 705183031
- Labeler code
- 70518
- Product ID
- 70518-3031_4dec8664-b51f-da36-e063-6294a90a4edb
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Glycopyrrolate
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- REMEDYREPACK INC.
- Application
- ANDA207201
- Marketing category
- ANDA
- Marketing start
- 2021-02-25
- Substance
- GLYCOPYRROLATE
- Active strength
- 2 mg/1
- Pharmacologic classes
- Anticholinergic [EPC], Cholinergic Antagonists [MoA], Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Observed NDC auxiliary status history#
This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
| Captured / source date | Snapshot | Source SHA-256 |
|---|---|---|
| 2025-12-14 17:58 UTC · source 2025-12-05 | d630ba8d3edf… | 732f749b63fb… |
| 2025-08-27 00:01 UTC · source 2025-08-26 | f5e01cc5f278… | a2eaf40c39c3… |
| 2025-04-01 02:39 UTC · source 2025-03-31 | 2ef7874e63bc… | 57b86245f4fa… |
| 2025-03-28 20:22 UTC · source 2025-03-28 | a1b67e2a42f9… | c4cf2c586c0d… |
| 2025-03-22 03:12 UTC · source 2025-03-21 | cfe11265f3b6… | 090c488252e2… |
| 2025-03-10 12:48 UTC · source 2025-03-10 | cdf11ea48f46… | ba0047e9e063… |
| 2025-02-02 03:52 UTC · source 2025-01-31 | 302b2466d912… | e7b80fea0513… |
| 2025-01-20 13:05 UTC · source 2025-01-20 | ed331223b511… | 672a5bd82f5f… |
| 2025-01-11 03:41 UTC · source 2025-01-10 | 0efc9e666f02… | f202fb6c5f17… |
| 2024-11-09 02:27 UTC · source 2024-11-08 | ad56d346431e… | cc804d4bbf1e… |
| 2024-10-04 04:10 UTC · source 2024-10-03 | 367a005e9d99… | 383a685ebd0f… |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A207201-001 | GLYCOPYRROLATE | GLYCOPYRROLATE | 1MG | TABLET / ORAL | AA | 2017-01-03 | |
| A207201-002 | GLYCOPYRROLATE | GLYCOPYRROLATE | 2MG | TABLET / ORAL | AA | 2017-01-03 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A207201-001 | AA |
| A207201-002 | AA |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | A207201-001 | GLYCOPYRROLATE | 1MG | TABLET / ORAL | AA | 2017-01-03 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A207201-002 | GLYCOPYRROLATE | 2MG | TABLET / ORAL | AA | 2017-01-03 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A207201-001 | GLYCOPYRROLATE | 1MG | TABLET / ORAL | AA | 2017-01-03 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A207201-002 | GLYCOPYRROLATE | 2MG | TABLET / ORAL | AA | 2017-01-03 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | A207201-001 | GLYCOPYRROLATE | 1MG | TABLET / ORAL | AA | 2017-01-03 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A207201-002 | GLYCOPYRROLATE | 2MG | TABLET / ORAL | AA | 2017-01-03 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A207201-001 | GLYCOPYRROLATE | 1MG | TABLET / ORAL | AA | 2017-01-03 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A207201-002 | GLYCOPYRROLATE | 2MG | TABLET / ORAL | AA | 2017-01-03 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A207201-001 | GLYCOPYRROLATE | 1MG | TABLET / ORAL | AA | 2017-01-03 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A207201-002 | GLYCOPYRROLATE | 2MG | TABLET / ORAL | AA | 2017-01-03 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A207201-001 | GLYCOPYRROLATE | 1MG | TABLET / ORAL | AA | 2017-01-03 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A207201-002 | GLYCOPYRROLATE | 2MG | TABLET / ORAL | AA | 2017-01-03 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A207201-001 | GLYCOPYRROLATE | 1MG | TABLET / ORAL | AA | 2017-01-03 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A207201-002 | GLYCOPYRROLATE | 2MG | TABLET / ORAL | AA | 2017-01-03 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A207201-001 | GLYCOPYRROLATE | 1MG | TABLET / ORAL | AA | 2017-01-03 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A207201-002 | GLYCOPYRROLATE | 2MG | TABLET / ORAL | AA | 2017-01-03 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A207201-001 | GLYCOPYRROLATE | 1MG | TABLET / ORAL | AA | 2017-01-03 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A207201-002 | GLYCOPYRROLATE | 2MG | TABLET / ORAL | AA | 2017-01-03 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | A207201-001 | GLYCOPYRROLATE | 1MG | TABLET / ORAL | AA | 2017-01-03 | d06236e962d9… | |
| 2024-10-29 15:01 UTC | 2024-10 | A207201-002 | GLYCOPYRROLATE | 2MG | TABLET / ORAL | AA | 2017-01-03 | d06236e962d9… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A207201-001 | GLYCOPYRROLATE | 1MG | TABLET / ORAL | AA | 2017-01-03 | 79d66fd596c7… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A207201-002 | GLYCOPYRROLATE | 2MG | TABLET / ORAL | AA | 2017-01-03 | 79d66fd596c7… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A207201-001 | GLYCOPYRROLATE | 1MG | TABLET / ORAL | AA | 2017-01-03 | 301d65b070ca… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A207201-002 | GLYCOPYRROLATE | 2MG | TABLET / ORAL | AA | 2017-01-03 | 301d65b070ca… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A207201-001 | GLYCOPYRROLATE | 1MG | TABLET / ORAL | AA | 2017-01-03 | 1e350fbaab3a… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A207201-002 | GLYCOPYRROLATE | 2MG | TABLET / ORAL | AA | 2017-01-03 | 1e350fbaab3a… | |
| 2024-05-31 18:47 UTC | 2024-05 | A207201-001 | GLYCOPYRROLATE | 1MG | TABLET / ORAL | AA | 2017-01-03 | 8072bd15b7f6… | |
| 2024-05-31 18:47 UTC | 2024-05 | A207201-002 | GLYCOPYRROLATE | 2MG | TABLET / ORAL | AA | 2017-01-03 | 8072bd15b7f6… | |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A207201-001 | GLYCOPYRROLATE | 1MG | TABLET / ORAL | AA | 2017-01-03 | 5c6f7cd8ea54… | |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A207201-002 | GLYCOPYRROLATE | 2MG | TABLET / ORAL | AA | 2017-01-03 | 5c6f7cd8ea54… | |
| 2022-04-08 23:34 UTC | 2022-04 | A207201-001 | GLYCOPYRROLATE | 1MG | TABLET / ORAL | AA | 2017-01-03 | 5d02ea3f76ae… | |
| 2022-04-08 23:34 UTC | 2022-04 | A207201-002 | GLYCOPYRROLATE | 2MG | TABLET / ORAL | AA | 2017-01-03 | 5d02ea3f76ae… | |
| 2022-04-04 05:41 UTC | 2022-04 | A207201-001 | GLYCOPYRROLATE | 1MG | TABLET / ORAL | AA | 2017-01-03 | 4b0b4de00fa7… | |
| 2022-04-04 05:41 UTC | 2022-04 | A207201-002 | GLYCOPYRROLATE | 2MG | TABLET / ORAL | AA | 2017-01-03 | 4b0b4de00fa7… | |
| 2019-12-13 00:20 UTC | 2019-12 | A207201-001 | GLYCOPYRROLATE | 1MG | TABLET / ORAL | AA | 2017-01-03 | 74a2ff9319b5… | |
| 2019-12-13 00:20 UTC | 2019-12 | A207201-002 | GLYCOPYRROLATE | 2MG | TABLET / ORAL | AA | 2017-01-03 | 74a2ff9319b5… | |
| 2022-03-09 01:35 UTC | 2022-03 | A207201-001 | GLYCOPYRROLATE | 1MG | TABLET / ORAL | AA | 2017-01-03 | bb7c543d1eb4… | |
| 2022-03-09 01:35 UTC | 2022-03 | A207201-002 | GLYCOPYRROLATE | 2MG | TABLET / ORAL | AA | 2017-01-03 | bb7c543d1eb4… | |
| 2021-12-28 21:50 UTC | 2021-12 | A207201-001 | GLYCOPYRROLATE | 1MG | TABLET / ORAL | AA | 2017-01-03 | 782e0a99824c… | |
| 2021-12-28 21:50 UTC | 2021-12 | A207201-002 | GLYCOPYRROLATE | 2MG | TABLET / ORAL | AA | 2017-01-03 | 782e0a99824c… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | A207201-001 | AA | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A207201-002 | AA | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A207201-001 | AA | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A207201-002 | AA | 1 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | A207201-001 | AA | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A207201-002 | AA | 1 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A207201-001 | AA | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A207201-002 | AA | 1 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A207201-001 | AA | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A207201-002 | AA | 1 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A207201-001 | AA | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A207201-002 | AA | 1 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A207201-001 | AA | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A207201-002 | AA | 1 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A207201-001 | AA | 1 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A207201-002 | AA | 1 | 5bbf6a4d5a75… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A207201-001 | AA | 1 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A207201-002 | AA | 1 | d8e5a09893c0… |
| 2024-10-29 15:01 UTC | 2024-10 | A207201-001 | AA | 1 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | A207201-002 | AA | 1 | d06236e962d9… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A207201-001 | AA | 1 | 79d66fd596c7… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A207201-002 | AA | 1 | 79d66fd596c7… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A207201-001 | AA | 1 | 301d65b070ca… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A207201-002 | AA | 1 | 301d65b070ca… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A207201-001 | AA | 1 | 1e350fbaab3a… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A207201-002 | AA | 1 | 1e350fbaab3a… |
| 2024-05-31 18:47 UTC | 2024-05 | A207201-001 | AA | 1 | 8072bd15b7f6… |
| 2024-05-31 18:47 UTC | 2024-05 | A207201-002 | AA | 1 | 8072bd15b7f6… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A207201-001 | AA | 1 | 5c6f7cd8ea54… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A207201-002 | AA | 1 | 5c6f7cd8ea54… |
| 2022-04-08 23:34 UTC | 2022-04 | A207201-001 | AA | 1 | 5d02ea3f76ae… |
| 2022-04-08 23:34 UTC | 2022-04 | A207201-002 | AA | 1 | 5d02ea3f76ae… |
| 2022-04-04 05:41 UTC | 2022-04 | A207201-001 | AA | 1 | 4b0b4de00fa7… |
| 2022-04-04 05:41 UTC | 2022-04 | A207201-002 | AA | 1 | 4b0b4de00fa7… |
| 2019-12-13 00:20 UTC | 2019-12 | A207201-001 | AA | 1 | 74a2ff9319b5… |
| 2019-12-13 00:20 UTC | 2019-12 | A207201-002 | AA | 1 | 74a2ff9319b5… |
| 2022-03-09 01:35 UTC | 2022-03 | A207201-001 | AA | 1 | bb7c543d1eb4… |
| 2022-03-09 01:35 UTC | 2022-03 | A207201-002 | AA | 1 | bb7c543d1eb4… |
| 2021-12-28 21:50 UTC | 2021-12 | A207201-001 | AA | 1 | 782e0a99824c… |
| 2021-12-28 21:50 UTC | 2021-12 | A207201-002 | AA | 1 | 782e0a99824c… |
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Glycopyrrolate
- Listing expiration
- 2027-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| GLYCOPYRROLATE | 2 mg/1 |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| V92SO9WP2I | Internal UNII lookup |
Harmonized RxCUI identifiers#
| Identifier | FDA.report destination |
|---|---|
| 197739 | Internal RxNorm lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| fafea739-87d0-4421-833f-eb066791504c | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 138c3de2-4b03-4255-92b5-f022482d81bc | Product name | 4 | 20260113 |
| 4dc252b1-bb5f-8bb6-4fa8-f3a45efd810e | Product name | 5 | 20250304 |
| f58f10d3-5fa9-4c2e-9a6e-77029e9ed80b | Product name | 1 | 20231002 |
| 76dcac30-469f-4f92-9c55-70950d209446 | Product name | 1 | 20230809 |
| 132196a6-5117-4b6e-a9dd-27f2793580c6 | Product name | 1 | 20230112 |
| ac1f888b-a1db-4d2e-abbc-973f21c2ce1b | Product name | 1 | 20220720 |
| d84dd569-7bf0-1410-25eb-017ef37dd406 | Product name | 9 | 20210902 |
| 7d8c8d5a-f174-4e6b-97b1-6fd615c5df9a | Product name | 1 | 20210204 |
| 58b12de9-b891-41c7-9be6-ff47de5ec28b | Product name | 1 | 20180828 |
| 9aff7b10-8e47-4b10-9a92-803440a37ce2 | Product name | 1 | 20180206 |
| ce066c73-ca6f-49fc-83d4-d3cf6728e8a1 | Product name | 1 | 20160616 |
| fb29b8a9-c2d0-42bb-aea8-9bc2a87db75a | Product name | 1 | 20151113 |
| ab7ba50c-5a47-47e6-8dd6-fa32a52559f6 | Product name | 1 | 20151109 |
| 29ae08d1-069f-9822-4820-152d5dc67797 | Product name | 1 | 20140508 |
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 70518-3031-0 | Glycopyrrolate | 100 in 1 BOX | TABLET | 100 | 5 | |
| 70518-3031-1 | Glycopyrrolate | 1 in 1 POUCH | TABLET | 1 | 5 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Glycopyrrolate | GLYCOPYRROLATE | REMEDYREPACK INC. | a338ef22-c243-4075-b02d-bcd5b590104a | 2026-03-26 | Warnings, Adverse reactions | 207201 ANDA207201 |
| Glycopyrrolate | GLYCOPYRROLATE | REMEDYREPACK INC. | fafea739-87d0-4421-833f-eb066791504c | 2026-03-26 | Warnings, Adverse reactions | 207201 ANDA207201 70518-3031-0 70518-3031 70518303100 |
| Glycopyrrolate | GLYCOPYRROLATE | Major Pharmaceuticals | 6e5bfe6d-d321-4f0f-86e2-457d8fd10a6a | 2026-03-19 | Warnings, Adverse reactions | 207201 ANDA207201 |
| Glycopyrrolate | GLYCOPYRROLATE | Chartwell RX, LLC | 5773cf63-4006-4d8f-b53b-c84bcfe19e4a | 2025-12-10 | Warnings, Adverse reactions | 207201 ANDA207201 |
| Glycopyrrolate | GLYCOPYRROLATE | Bryant Ranch Prepack | bfccdb26-5047-4b54-9732-ffac2d78e4d1 | 2024-05-29 | Warnings, Adverse reactions | 207201 ANDA207201 |
| Glycopyrrolate | GLYCOPYRROLATE | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | 26cdd84d-ffa0-4e52-b359-4acef4bd8093 | 2022-11-10 | Warnings, Adverse reactions | 207201 ANDA207201 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 197739 | glycopyrrolate 2 MG Oral Tablet | PSN | fafea739-87d0-4421-833f-eb066791504c | 5 |
| 197739 | glycopyrrolate 2 MG Oral Tablet | SCD | fafea739-87d0-4421-833f-eb066791504c | 5 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 70518-3031-0 | 70518303100 | 100 POUCH in 1 BOX (70518-3031-0) / 1 TABLET in 1 POUCH (70518-3031-1) | 100 pouch | 2021-02-25 | 0000-00-00 | No | No | Current |